Navigation Links
Research network at St. Michael's gets $4.7 million to study classes of drugs
Date:7/5/2013

TORONTO, July 5, 2013An Ontario-wide research network based at St. Michael's Hospital has received a three-year, $4.7 million grant from the province of Ontario to conduct policy-driven prescription drug research.

The grant from the Health Services Research Fund was awarded to the Ontario Drug Policy Research Network to bridge drug policy and research. The co-principal investigators of the network are Tara Gomes and Dr. Muhammad Mamdani, both scientists at the hospital's Li Ka Shing Knowledge Institute, as well as Dr. David Juurlink of Sunnybrook Health Sciences Centre.

Since being established in 2008, the network has worked directly with health policy-makers in Ontario to generate rigorous evidence related to drug safety, effectiveness and costs to inform drug policy. This new grant will allow the network to conduct comprehensive reviews of entire classes of drugs, rather than individual drugs, and will nearly double its full-time and part-time staff to approximately 15 people, Gomes said.

Gomes said their work will include systematic reviews of literature, economic analyses, pharmacoepidemiologic evaluations, and qualitative studies of the perceptions and values of patients, prescribers and pharmacists. This work will consider a broad range of areas, including the effectiveness of the drugs, potential side effects, how they are being prescribed in Ontario and the cost implications of any changes to their coverage on the public drug plan. Ontario spends nearly $5 billion annually on core drug programs, making it one of the world's largest public payers for drugs. Work by the Ontario Drug Policy Research Network so far has the potential to save the Ontario health care system at least $26 million in spending over the next five years, while at the same time improving the quality of care and health outcomes.

"Our network provides Ontario decision-makers with evidence to inform drug policy decisions and to ensure that drugs are provided in a way that is safe, cost-effective, and that aligns with patient and provider values," Gomes said.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert

Related medicine news :

1. New research could pave the way to safer treatments for arthritis
2. IRCM scientists find a novel research model for the study of auto-immune diseases
3. Researcher warns banned fountain of youth drug may be making a comeback
4. IOF 4th Asia-Pacific Osteoporosis Meeting is influential forum for regional bone research
5. Researchers pinpoint sources of fibrosis-promoting cells that ravage organs
6. Researchers use immunocytochemistry to determine ALK status
7. Researchers find 2 new methods to determine ALK status
8. CWRU researchers trace inner-city womens health issues to childhood traumas
9. Penn Medicine researchers discover link between fear and sound perception
10. Grant to further childhood sarcoma therapeutic research
11. UCI researchers awarded $2.27 million to create novel diabetes treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California ... combat pancreatic cancer. , Gary D. Radine, who recently retired as president and CEO ... Cancer Society’s 2015 CEO of the Year , helped lead the effort to ...
(Date:2/8/2016)... ... , ... FileHold's document management software has been implemented by ... environment for FileHold software that is pay per user subscription-based and also does ... FileHold web services API. DocuSyst also advises clients on fully functioning back up ...
(Date:2/8/2016)... ... February 08, 2016 , ... TopConsumerReviews.com recently awarded their highest ... products. , Moles are derived from a cluster of melanin when exposed to sunlight. ... places and create a lifetime of embarrassment. Historically, mole removal has involved ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... four states in the U.S. require dental technicians to be certified or obtain ... dental industry, NADL created the “What’s In Your Mouth?” campaign to inform dentists ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... DIEGO , Feb. 8, 2016 /PRNewswire/--  Cell ... announced that advanced tissue-engineering services are now available ... a groundbreaking new three-dimensional (3D) bioprinting approach called ... 3D Bio Printer , a state-of-the-art robotic system ... has created a powerful pay-for-service bio-printing model that ...
(Date:2/8/2016)... 8, 2016 Velano Vascular, a medical technology ... patients and their practitioners, announced today that the company ... will use the proceeds from this financing, an extension ... January 2015, to support the development and commercialization of ... populations. Philadelphia , and ...
(Date:2/8/2016)... 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... delivery systems, today announced that it will release its financial ... 2015 after market close on February 9, 2016.  At this ... discuss these financial results.    About Unilife Corporation ... About Unilife Corporation UNIS ...
Breaking Medicine Technology: